B. Riley Financial Varied
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Globus Medical, Inc. Class A Common Stock (NY:GMED)

79.59 -0.53 (-0.66%)
Streaming Delayed Price Updated: 12:19 PM EDT, Jul 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Globus Medical, Inc. Class A Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
News headline image
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
News headline image
The Analyst Verdict: Globus Medical In The Eyes Of 7 Experts ↗
 
Via Benzinga
News headline image
Globus Medical Launches the Next Wave of Orthopedic Trauma Solutions
From Globus Medical
Via GlobeNewswire
News headline image
NYSE:GMED is showing good growth, while it is not too expensive. ↗
In the world of growth stocks, NYSE:GMED shines as a value proposition. 
Via Chartmill
News headline image
Looking Into Globus Medical's Recent Short Interest ↗
 
Via Benzinga
News headline image
A Glimpse Into The Expert Outlook On Globus Medical Through 8 Analysts ↗
 
Via Benzinga
News headline image
Looking Into Globus Medical's Recent Short Interest ↗
 
Via Benzinga
News headline image
What 8 Analyst Ratings Have To Say About Globus Medical ↗
 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Bragar Eagel & Squire, P.C. Is Investigating MaxLinear, Customers Bancorp, Globus, and Metagenomi and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
While growth is established for NYSE:GMED, the stock's valuation remains reasonable. ↗
While growth is established for NYSE:GMED, the stock's valuation remains reasonable. 
Via Chartmill
News headline image
Bragar Eagel & Squire, P.C. Is Investigating MaxLinear, Customers Bancorp, Globus, and Domino’s and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
NYSE:GMED is showing decent growth, but is still valued reasonably. ↗
NYSE:GMED, a growth stock which is not overvalued. 
Via Chartmill
News headline image
Bragar Eagel & Squire, P.C. Is Investigating Centuri, Medpace, Customers Bancorp, and Globus and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Globus Medical, Inc. (GMED) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
GMED Investors Have Opportunity to Join Globus Medical, Inc. Securities Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
Peering Into Globus Medical's Recent Short Interest ↗
 
Via Benzinga
News headline image
Globus Medical Launches ADIRA™ XLIF™ Plate System
From Globus Medical
Via GlobeNewswire
News headline image
Investors should take note of NYSE:GMED, a growth stock that remains attractively priced. ↗
GLOBUS MEDICAL INC - A (NYSE:GMED) stands out as a growth opportunity that won't break the bank. 
Via Chartmill
News headline image
GLOBUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Globus Medical, Inc. on Behalf of Globus Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Globus Medical, Inc. (GMED) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Globus Medical, Inc. (GMED)
From Kirby McInerney LLP
Via Business Wire
News headline image
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Globus Medical, Inc. (GMED) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Globus Medical, Inc. (GMED) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Announces Investigation of Globus Medical, Inc. (GMED) on Behalf of Investors
From Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Globus Medical (GMED) Q2 2024 Earnings Call Transcript ↗
GMED earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
GMED Stock Earnings: Globus Medical Beats EPS, Beats Revenue for Q2 2024 ↗
GMED stock results show that Globus Medical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Globus Medical Reports Second Quarter 2024 Results
From Globus Medical
Via GlobeNewswire
News headline image
Globus Medical Receives FDA 510(k) Clearance for ExcelsiusFlex™ and ACTIFY™ 3D Total Knee System
From Globus Medical
Via GlobeNewswire
News headline image
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
B. Riley Financial's diverse suite of services goes beyond traditional financial service offerings. By leveraging cross-platform expertise and assets, B. Riley Financial companies are uniquely positioned to provide full service, collaborative solutions to our clients at every stage of the business life cycle and in all market conditions.

B. Riley refers to B. Riley Financial, Inc. and/or one or more of its subsidiaries or affiliates. Click here for further details.